 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

For the last three days, A.I.dvisor has detected that GLUE's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Monte Rosa Therapeutics (GLUE, $6.01) Aroon Indicator entered a Downtrend on September 15, 2023.

Monte Rosa Therapeutics (GLUE, $5.98) Aroon Indicator entered a Downtrend on September 13, 2023.

Monte Rosa Therapeutics (GLUE, $5.95) Aroon Indicator entered a Downtrend on September 12, 2023.

Monte Rosa Therapeutics (GLUE, $6.04) Aroon Indicator entered a Downtrend on September 11, 2023.

Monte Rosa Therapeutics (GLUE, $5.97) Aroon Indicator entered a Downtrend on September 08, 2023.

Monte Rosa Therapeutics (GLUE, $6) Aroon Indicator entered a Downtrend on September 07, 2023.

Monte Rosa Therapeutics (GLUE, $6.04) Aroon Indicator entered a Downtrend on September 06, 2023.

Monte Rosa Therapeutics (GLUE, $6.2) Aroon Indicator entered a Downtrend on September 01, 2023.

Monte Rosa Therapeutics (GLUE, $5.9) Aroon Indicator entered a Downtrend on August 31, 2023.

For the last three days, A.I.dvisor has detected that GLUE's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for GLUE, and traders may view it as a Sell signal for the next month. Traders may consider ...

Monte Rosa Therapeutics (GLUE, $6.3) Aroon Indicator entered a Downtrend on August 29, 2023.

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Watchers	118
52-Wk Low	$4.40
52-Wk High	$10.96

Market Cap	$277.54M
Volume (M)	5.00
52-Wk High	$10.96
52-Wk Low	$4.40

GLUE Monte Rosa Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals